Paper33374205
Focused Ultrasound and Microbubbles-Mediated Drug Delivery to Brain Tumor.
Wu SK and 3 others. Pharmaceutics, 2020. Cited by 89 papers, by iCite.
Cite this record
ConductScience Library. Focused Ultrasound and Microbubbles-Mediated Drug Delivery to Brain Tumor. Papers, record 33374205. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33374205
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References102
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28374753 | Acute effects of focused ultrasound-induced increases in blood-brain barrier permeability on rat microvascular transcriptome. | Sci Rep | 2017 | https://conductscience.org/library/papers/28374753 | PubMed |
| 2 | 24320540 | The application of sparse arrays in high frequency transcranial focused ultrasound therapy: a simulation study. | Med Phys | 2013 | https://conductscience.org/library/papers/24320540 | PubMed |
| 3 | 19560743 | Novel drug delivery strategies in neuro-oncology. | Neurotherapeutics | 2009 | https://conductscience.org/library/papers/19560743 | PubMed |
| 4 | 26359209 | Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma. | Neuro Oncol | 2016 | https://conductscience.org/library/papers/26359209 | PubMed |
| 5 | 20413754 | Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. | Radiology | 2010 | https://conductscience.org/library/papers/20413754 | PubMed |
| 6 | 30135559 | Whole-Brain Vasculature Reconstruction at the Single Capillary Level. | Sci Rep | 2018 | https://conductscience.org/library/papers/30135559 | PubMed |
| 7 | 27306666 | Clinical trial of blood-brain barrier disruption by pulsed ultrasound. | Sci Transl Med | 2016 | https://conductscience.org/library/papers/27306666 | PubMed |
| 8 | 20401670 | Efficacy of monoterpene perillyl alcohol upon survival rate of patients with recurrent glioblastoma. | J Cancer Res Clin Oncol | 2011 | https://conductscience.org/library/papers/20401670 | PubMed |
| 9 | 25936845 | Focused ultrasound-mediated drug delivery through the blood-brain barrier. | Expert Rev Neurother | 2015 | https://conductscience.org/library/papers/25936845 | PubMed |
| 10 | 31779126 | Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials. | Molecules | 2019 | https://conductscience.org/library/papers/31779126 | PubMed |
| 11 | 31831565 | Ultrasound-mediated Delivery of Paclitaxel for Glioma: A Comparative Study of Distribution, Toxicity, and Efficacy of Albumin-bound Versus Cremophor Formulations. | Clin Cancer Res | 2020 | https://conductscience.org/library/papers/31831565 | PubMed |
| 12 | 16525177 | Physiologic and metabolic magnetic resonance imaging in gliomas. | J Clin Oncol | 2006 | https://conductscience.org/library/papers/16525177 | PubMed |
| 13 | 23143192 | Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited. | Acta Neuropathol | 2012 | https://conductscience.org/library/papers/23143192 | PubMed |
| 14 | 11086016 | Tight junction, a platform for trafficking and signaling protein complexes. | J Cell Biol | 2000 | https://conductscience.org/library/papers/11086016 | PubMed |
| 15 | 18313204 | Hemorrhage detection during focused-ultrasound induced blood-brain-barrier opening by using susceptibility-weighted magnetic resonance imaging. | Ultrasound Med Biol | 2008 | https://conductscience.org/library/papers/18313204 | PubMed |
| 16 | 31899873 | Safety and feasibility of multiple blood-brain barrier disruptions for the treatment of glioblastoma in patients undergoing standard adjuvant chemotherapy. | J Neurosurg | 2021 | https://conductscience.org/library/papers/31899873 | PubMed |
| 17 | 28108988 | Blood-Brain Barrier Closure Time After Controlled Ultrasound-Induced Opening Is Independent of Opening Volume. | J Ultrasound Med | 2017 | https://conductscience.org/library/papers/28108988 | PubMed |
| 18 | 26829100 | Lauroyl-gemcitabine-loaded lipid nanocapsule hydrogel for the treatment of glioblastoma. | J Control Release | 2016 | https://conductscience.org/library/papers/26829100 | PubMed |
| 19 | 22405901 | Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme. | J Control Release | 2012 | https://conductscience.org/library/papers/22405901 | PubMed |
| 20 | 24416140 | Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101). | PLoS One | 2014 | https://conductscience.org/library/papers/24416140 | PubMed |
Cited by54
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42758253 | Advances in Nanomedicine for Brain Tumors: Overcoming Biological Barriers, Targeting Strategies, and Future Directions. | Curr Neurol Neurosci Rep | 2026 | https://conductscience.org/library/papers/42758253 | PubMed |
| 42436585 | The modulation of the blood-brain barrier by focused ultrasound stimulates oligodendrogenesis. | Acta Neuropathol Commun | 2026 | https://conductscience.org/library/papers/42436585 | PubMed |
| 42388505 | Reconceptualizing glioblastoma immunotherapy: a four-pillar framework to overcome multidimensional resistance. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42388505 | PubMed |
| 42281803 | Focused ultrasound for brain metastases. | Neurooncol Adv | 2026 | https://conductscience.org/library/papers/42281803 | PubMed |
| 42257792 | Integrating Molecular Pathology, Tumor Microenvironment, and Novel Therapies to Overcome Resistance in Glioblastoma. | J Mol Neurosci | 2026 | https://conductscience.org/library/papers/42257792 | PubMed |
| 41709060 | Molecular insights into glial neuroimmune cross reactivity with CNS antigens and its role in neuroinflammation. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/41709060 | PubMed |
| 41584353 | Endogenic transferrin-targeted cell membrane-coated biomimetic lipo-complexes for efficient targeting and enhanced antitumor efficacy in orthotopic glioblastoma. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/41584353 | PubMed |
| 41424850 | Focused ultrasound-enhanced nose-to-brain delivery of a therapeutic antibody in a large-animal model. | Theranostics | 2026 | https://conductscience.org/library/papers/41424850 | PubMed |
| 40682852 | Mechanism of action and therapeutic potential of S100A8/A9 in neuroinflammation and cognitive impairment: From molecular target to clinical application (Review). | Int J Mol Med | 2025 | https://conductscience.org/library/papers/40682852 | PubMed |
| 40574083 | Click on Click: Click-Flavone Glycosides Encapsulated in Click-Functionalised Polymersomes for Glioblastoma Therapy. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40574083 | PubMed |
| 40430951 | Advancing Brain Targeting: Cost-Effective Surface-Modified Nanoparticles for Faster Market Entry. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40430951 | PubMed |
| 40430568 | Near-Infrared Photoimmunotherapy in Brain Tumors-An Unexplored Frontier. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40430568 | PubMed |
| 40371021 | Nanotechnology Driven Lipid and Metalloid Based Formulations Targeting Blood-Brain Barrier (3B) for Brain Tumor. | Indian J Microbiol | 2025 | https://conductscience.org/library/papers/40371021 | PubMed |
| 39941807 | Advances in the Repurposing and Blood-Brain Barrier Penetrance of Drugs in Pediatric Brain Tumors. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/39941807 | PubMed |
| 39911305 | Combined Strategies for Nanodrugs Noninvasively Overcoming the Blood-Brain Barrier and Actively Targeting Glioma Lesions. | Biomater Res | 2025 | https://conductscience.org/library/papers/39911305 | PubMed |
| 39766134 | Innovative Approaches to Brain Cancer: The Use of Magnetic Resonance-guided Focused Ultrasound in Glioma Therapy. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39766134 | PubMed |
| 39713205 | Advancements and challenges in brain cancer therapeutics. | Exploration (Beijing) | 2024 | https://conductscience.org/library/papers/39713205 | PubMed |
| 39564781 | Overcoming challenges in the design of drug delivery systems targeting the central nervous system. | Nanomedicine (Lond) | 2025 | https://conductscience.org/library/papers/39564781 | PubMed |
| 39513304 | Unraveling Neurological Drug Delivery: Polymeric Nanocarriers for Enhanced Blood-Brain Barrier Penetration. | Curr Drug Targets | 2025 | https://conductscience.org/library/papers/39513304 | PubMed |
| 39309880 | A comprehensive review of advanced focused ultrasound (FUS) microbubbles-mediated treatment of Alzheimer's disease. | Heliyon | 2024 | https://conductscience.org/library/papers/39309880 | PubMed |
Genes13
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33374205
GET https://conductscience.org/api/papers/v1/33374205/references?page=2